Clorox expects its GOJO Industries acquisition, completed in April 2026 and now operating as Clorox Purell, to drive most of its reported sales growth in fiscal 2027. The company projects net sales to increase 13-14%, with GOJO contributing about 9.5 percentage points, and the combined global health and hygiene portfolio now represents more than half of net sales. Adjusted earnings are projected at $5.70-$6.00 per share, up 3-8%, while reported earnings are expected at $5.41-$5.71 per share, including about 29 cents of GOJO transaction-related costs. Clorox expects fiscal 2027 gross margin of about 42%, including roughly 20 basis points of pressure mainly from GOJO inventory step-up costs, and inflation to exceed $200 million, more than double its historical $75-$100 million range.
The Clorox CompanyGOJO acquisition drives fiscal 2027 sales growth and earnings guidance
Church & Dwight Company Inc
Procter & Gamble CompanyAcquired by Clorox, now operating as Clorox Purell, contributing to growth
